[go: up one dir, main page]

SG11201700652PA - Modified antimir-138 oligonucleotides - Google Patents

Modified antimir-138 oligonucleotides

Info

Publication number
SG11201700652PA
SG11201700652PA SG11201700652PA SG11201700652PA SG11201700652PA SG 11201700652P A SG11201700652P A SG 11201700652PA SG 11201700652P A SG11201700652P A SG 11201700652PA SG 11201700652P A SG11201700652P A SG 11201700652PA SG 11201700652P A SG11201700652P A SG 11201700652PA
Authority
SG
Singapore
Prior art keywords
oligonucleotides
modified antimir
antimir
modified
Prior art date
Application number
SG11201700652PA
Other languages
English (en)
Inventor
Prabha Sampath
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201700652PA priority Critical patent/SG11201700652PA/en
Publication of SG11201700652PA publication Critical patent/SG11201700652PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure
    • C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/50—Methods for regulating/modulating their activity
    • C12N2320/51—Methods for regulating/modulating their activity modulating the chemical stability, e.g. nuclease-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201700652PA 2014-07-31 2015-07-31 Modified antimir-138 oligonucleotides SG11201700652PA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201700652PA SG11201700652PA (en) 2014-07-31 2015-07-31 Modified antimir-138 oligonucleotides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201404535S 2014-07-31
PCT/SG2015/050245 WO2016018193A1 (en) 2014-07-31 2015-07-31 Modified antimir-138 oligonucleotides
SG11201700652PA SG11201700652PA (en) 2014-07-31 2015-07-31 Modified antimir-138 oligonucleotides

Publications (1)

Publication Number Publication Date
SG11201700652PA true SG11201700652PA (en) 2017-02-27

Family

ID=55217923

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700652PA SG11201700652PA (en) 2014-07-31 2015-07-31 Modified antimir-138 oligonucleotides

Country Status (6)

Country Link
US (1) US10472626B2 (ja)
EP (1) EP3177722A4 (ja)
JP (2) JP6819907B2 (ja)
CN (1) CN106536736B (ja)
SG (1) SG11201700652PA (ja)
WO (1) WO2016018193A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6819907B2 (ja) * 2014-07-31 2021-01-27 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 修飾抗ｍｉｒ−１３８オリゴヌクレオチド
CN110724688A (zh) * 2019-10-09 2020-01-24 新乡医学院 miRNA138及其在调节TERT基因表达中的应用
CN112220778B (zh) * 2020-10-16 2022-11-11 中国药科大学 一种用于肺动脉高压治疗的联合递送系统及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2530157B1 (en) * 2003-07-31 2016-09-28 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of miRNAs
CA2620856C (en) * 2005-08-29 2017-11-28 Isis Pharmaceuticals, Inc. Methods for use in modulating mir-122a
EP2007889A2 (en) * 2006-04-03 2008-12-31 Santaris Pharma A/S Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides
ES2406686T3 (es) * 2007-10-04 2013-06-07 Santaris Pharma A/S Micromirs
WO2010099161A1 (en) * 2009-02-26 2010-09-02 The Ohio State University Research Foundation Micrornas in never-smokers and related materials and methods
WO2012087242A1 (en) * 2010-12-20 2012-06-28 Agency For Science, Technology And Research Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138
EP2681336A4 (en) * 2011-03-02 2014-11-19 Groove Biopharma Corp ENHANCED BIODISTRIBUTION OF OLIGOMERS
WO2012121178A1 (ja) * 2011-03-04 2012-09-13 独立行政法人国立がん研究センター 腫瘍血管形成阻害剤
US20140194491A1 (en) * 2011-06-24 2014-07-10 Syddansk Universitet Modulation of microrna-138 for the treatment of bone loss
US20150045410A1 (en) * 2012-02-06 2015-02-12 University Of Iowa Research Foundation Method of regulating cftr expression and processing
DK2951305T3 (en) * 2013-01-30 2018-10-29 Hoffmann La Roche LNA oligonucleotide KULHYDRATKONJUGATER
JP6819907B2 (ja) * 2014-07-31 2021-01-27 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ 修飾抗ｍｉｒ−１３８オリゴヌクレオチド

Also Published As

Publication number Publication date
US20170260526A1 (en) 2017-09-14
JP2017522875A (ja) 2017-08-17
EP3177722A4 (en) 2018-01-17
US10472626B2 (en) 2019-11-12
CN106536736B (zh) 2021-02-19
JP6819907B2 (ja) 2021-01-27
WO2016018193A1 (en) 2016-02-04
JP2020202845A (ja) 2020-12-24
CN106536736A (zh) 2017-03-22
EP3177722A1 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
DK3237446T3 (en) Anti-PD-1-antistoffer
DK3236972T3 (en) Antivirale N4-hydroxycytidin-derivativer
DK3373003T3 (en) Urinteststrimmel
AU361515S (en) Dishrack
AU362944S (en) Lapboard
GB201503408D0 (en) Oligonucleotides
GB201504124D0 (en) Oligonucleotides
DK3191586T3 (en) Cellobiosephosphorylase
DK3178931T3 (en) Anti-orai1-antistof
LT3237349T (lt) Patobulintas biologinis rišiklis
DK3002465T3 (en) Hydrauliksystem
SG11201700652PA (en) Modified antimir-138 oligonucleotides
DK3194944T3 (en) Tomografiapparat
GB201419650D0 (en) Modified heterocyclase
DK3145380T3 (en) Toiletventilationssystem
DK3234061T3 (en) Nano-inhibitorer
AU5592P (en) Lanmichigan Mandevilla boliviensis x sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi